We provide you with 20 years of free, institutional-grade data for MYNZ stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MYNZ. Explore the full financial landscape of MYNZ stock.
| Reported Date | CIK | Ticker | Type |
|---|
Mainz Biomed B.V.(NASDAQ:MYNZ) 
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoS...
Share this website to your friends
The information provided in this report about MYNZ stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.